Depts. of Medicine and Pharmacology, Univ. of California San Diego and VASDHCS, 3350 La Jolla Village Dr. (9151 San Diego, CA 92161, USA.
Am J Physiol Renal Physiol. 2012 May 15;302(10):F1293-9. doi: 10.1152/ajprenal.00013.2012. Epub 2012 Feb 15.
Tubular secretion of the organic cation, creatinine, limits its value as a marker of glomerular filtration rate (GFR) but the molecular determinants of this pathway are unclear. The organic anion transporters, OAT1 and OAT3, are expressed on the basolateral membrane of the proximal tubule and transport organic anions but also neutral compounds and cations. Here, we demonstrate specific uptake of creatinine into mouse mOat1- and mOat3-microinjected Xenopus laevis oocytes at a concentration of 10 μM (i.e., similar to physiological plasma levels), which was inhibited by both probenecid and cimetidine, prototypical competitive inhibitors of organic anion and cation transporters, respectively. Renal creatinine clearance was consistently greater than inulin clearance (as a measure of GFR) in wild-type (WT) mice but not in mice lacking OAT1 (Oat1-/-) and OAT3 (Oat3-/-). WT mice presented renal creatinine net secretion (0.23 ± 0.03 μg/min) which represented 45 ± 6% of total renal creatinine excretion. Mean values for renal creatinine net secretion and renal creatinine secretion fraction were not different from zero in Oat1-/- (-0.03 ± 0.10 μg/min; -3 ± 18%) and Oat3-/- (0.01 ± 0.06 μg/min; -6 ± 19%), with greater variability in Oat1-/-. Expression of OAT3 protein in the renal membranes of Oat1-/- mice was reduced to ∼6% of WT levels, and that of OAT1 in Oat3-/- mice to ∼60%, possibly as a consequence of the genes for Oat1 and Oat3 having adjacent chromosomal locations. Plasma creatinine concentrations of Oat3-/- were elevated in clearance studies under anesthesia but not following brief isoflurane anesthesia, indicating that the former condition enhanced the quantitative contribution of OAT3 for renal creatinine secretion. The results are consistent with a contribution of OAT3 and possibly OAT1 to renal creatinine secretion in mice.
有机阳离子肌酐的管状分泌限制了其作为肾小球滤过率(GFR)标志物的价值,但该途径的分子决定因素尚不清楚。有机阴离子转运体 OAT1 和 OAT3 表达在近端肾小管的基底外侧膜上,可转运有机阴离子,但也可转运中性化合物和阳离子。在这里,我们证明了肌酐在浓度为 10 μM(即类似于生理血浆水平)时被特异性摄取到小鼠 mOat1 和 mOat3 微注射非洲爪蟾卵母细胞中,这被丙磺舒和西咪替丁(分别为有机阴离子和阳离子转运体的典型竞争性抑制剂)抑制。在野生型(WT)小鼠中,肾脏肌酐清除率始终大于菊粉清除率(作为 GFR 的指标),但在缺乏 OAT1(Oat1-/-)和 OAT3(Oat3-/-)的小鼠中则不然。WT 小鼠表现出肾脏肌酐净分泌(0.23±0.03μg/min),占肾脏肌酐总排泄量的 45±6%。在 Oat1-/-(-0.03±0.10μg/min;-3±18%)和 Oat3-/-(0.01±0.06μg/min;-6±19%)中,肾脏肌酐净分泌和肾脏肌酐分泌分数的平均值均与零值无差异,而在 Oat1-/-中则存在更大的变异性。在 Oat1-/-小鼠的肾脏膜中,OAT3 蛋白的表达减少到 WT 水平的约 6%,而 Oat3-/-小鼠中 OAT1 的表达减少到约 60%,这可能是由于 Oat1 和 Oat3 的基因具有相邻的染色体位置。在麻醉下进行清除研究时,Oat3-/-小鼠的血浆肌酐浓度升高,但在短暂异氟烷麻醉后则没有升高,这表明前者条件增强了 OAT3 对肾脏肌酐分泌的定量贡献。这些结果与 OAT3 可能还有 OAT1 对小鼠肾脏肌酐分泌的贡献一致。